This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2001 Jan;22(1):3-4.

doi: 10.1016/s0165-6147(00)01606-0.

Pharmacogenetics and pharmacogenomics: tailored drug therapy for the 21st century

S F Grant¹

Affiliations

PMID: 11261414
DOI: 10.1016/s0165-6147(00)01606-0

Pharmacogenetics and pharmacogenomics: tailored drug therapy for the 21st century

S F Grant. Trends Pharmacol Sci. 2001 Jan.

. 2001 Jan;22(1):3-4.

doi: 10.1016/s0165-6147(00)01606-0.

Author

S F Grant¹

Affiliation

¹ LION Bioscience AG, Im Neuenheimer Feld 515-517, D-69120 Heidelberg, Germany. struan.grant@lionbioscience.com

PMID: 11261414
DOI: 10.1016/s0165-6147(00)01606-0

No abstract available

PubMed Disclaimer

Comment in

The perils of using the human genome sequence: lessons from CALCRL.
Conner AC, Poyner DR. Conner AC, et al. Trends Pharmacol Sci. 2001 Jun;22(6):272. doi: 10.1016/s0165-6147(00)01721-1. Trends Pharmacol Sci. 2001. PMID: 11436854 No abstract available.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science